News

Version 41.2 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of two new studies on disease-modifying treatments: Canakinumab NEW – one new study comparing canakinumab to placebo in 454 hospitalised patients with severe COVID-19 (Caricchio et al.) Azithromycin – one new study comparing azithromycin to placebo in 263 adult outpatients with COVID-19 (Oldenburg...

Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   - Lopinavir-ritonavir...

Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include:   Dutasteride - preprint publication status has been removed from the summary information...

Following a well-earned break, the Taskforce team has now returned to full capacity. Global evidence surveillance continued throughout January, with six clinical panel meetings held since January 11....

WEEK IN REVIEW Six-month milestone for the Taskforce There was great anxiety among clinicians back in March, as Australia prepared to face the first wave of the COVID-19 pandemic and the...